Selective Antitumoral Effect of Sorafenib Loaded PLGA Nanoparticles Conjugated with Cetuximab on Undifferentiated/Anaplastic Thyroid Carcinoma Cells

Mato E^2,3#, Puras G^1,2#, Bell O^2,3, Agirre M^1,2, Hernández RM^1,2, Igartua M^1,2, Moreno R¹, Gonzalez G^2,3, Alberto De Leiva Hidalgo^2,3* and Jose Luis Pedraz^1,2*

¹Nano Bio Cel Group, University of the Basque Country, Vitoria, Spain

²Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain

³EDUAB-HSP Neoplasia Thyroid Study Group, IIB, Autonomous University of Barcelona, Spain

^#Contributed equally to this work

^*Corresponding Author(s):